Applications — HPLCmart

Classification

Compound

Mode

More criteria

Column vendor

Length, mm

Int. diameter, mm

Particle size, μm

Pore size, Å

Found 4,302

Already have a column?

Column name

Showing 4,302 applications

Sort by:

ID	Classification	Compounds	Linked columns
PDF 3568	Drugs Pharmaceuticals	1 compounds Proglumide	Phenomenex Chirex 3010 250 × 4.6 mm · 5.0 µm
PDF 3567	Drugs Pharmaceuticals	1 compounds Propranolol	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3566	Drugs Pharmaceuticals	1 compounds Quinacrine	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3565	Antihistamines Drugs Pharmaceuticals	1 compounds Terfenadine	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3564	Antihistamines Drugs Pharmaceuticals	1 compounds Terfenadine	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3563	Drugs Pharmaceuticals	1 compounds Metoprolol	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3561	Drugs Pharmaceuticals	1 compounds Metoprolol	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3560	Drugs Pharmaceuticals	1 compounds Midodrine	Phenomenex Chirex 3001 250 × 4.6 mm · 5.0 µm
PDF 3559	Drugs Pharmaceuticals	1 compounds Nefopam	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3558	Alkaloids Biochemistry	1 compounds Nicotine	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3557	Drugs Pharmaceuticals	1 compounds Proglumide	Phenomenex Chirex 3005 250 × 4.6 mm · 5.0 µm
PDF 3554	Drugs Pharmaceuticals	1 compounds Proglumide	Phenomenex Chirex 3001 250 × 4.6 mm · 5.0 µm
PDF 3553	Drugs Pharmaceuticals	1 compounds Quinacrine	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3552	Drugs Pharmaceuticals	1 compounds Quinacrine	Phenomenex Chirex 3018 250 × 4.6 mm · 5.0 µm
PDF 3551	Drugs Pharmaceuticals	1 compounds Tetrahydrozoline	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3550	Drugs Pharmaceuticals	1 compounds Tetrahydrozoline	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3549	Alkaloids Biochemistry	1 compounds Nicotine	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3548	Drugs Pharmaceuticals	1 compounds Proglumide	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3547	Drugs Pharmaceuticals	1 compounds Thioridazine	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3546	Drugs Pharmaceuticals	1 compounds Quinacrine	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3545	Drugs Pharmaceuticals	1 compounds Tetrahydrozoline	Phenomenex Chirex 3018 250 × 4.6 mm · 5.0 µm
PDF 3544	Drugs Pharmaceuticals	1 compounds Thioridazine	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3543	Drugs Pharmaceuticals	1 compounds Timolol	Phenomenex Chirex 3005 250 × 4.6 mm · 5.0 µm
PDF 3542	Drugs Pharmaceuticals	1 compounds Tropicamide	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3541	Drugs Pharmaceuticals	1 compounds Tropicamide	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3540	Drugs Pharmaceuticals	1 compounds Verapamil	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3539	Drugs Pharmaceuticals	1 compounds Verapamil	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3538	Drugs Pharmaceuticals	1 compounds Verapamil	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3537	Amino Acids Biochemistry	2 compounds D-Phenylalanine L-Phenylalanine	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3536	Amino Acids Biochemistry	2 compounds D-Histidine L-Histidine	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3534	Not classified	2 compounds D-Phenylglycine L-Phenylglycine	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3533	Biochemistry Catecholamines	2 compounds D-DOPA [3-(3.4-dihydroxyphenyl)-alanine] L-DOPA [3-(3.4-dihydroxyphenyl)-alanine]	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3532	Drugs Pharmaceuticals	1 compounds Pranoprofen	Phenomenex Chirex 3011 250 × 4.6 mm · 5.0 µm
PDF 3531	Drugs Pharmaceuticals	1 compounds Baclofen	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3530	Amino Acids	1 compounds threo-3-Phenylserine	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3529	Not classified	1 compounds Naphthylglycine	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3528	Drugs Pharmaceuticals	1 compounds Midodrine	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3527	Amines Pharmaceuticals	1 compounds Octopamine	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3526	Drugs Pharmaceuticals	1 compounds Promethazine	Phenomenex Chirex 3020 250 × 4.6 mm · 5.0 µm
PDF 3525	Drugs Pharmaceuticals	1 compounds Suprofen	Phenomenex Chirex 3005 250 × 4.6 mm · 5.0 µm
PDF 3524	Amino Acids	1 compounds N-FMOC-phenylalanine	Phenomenex Chirex 3012 250 × 4.6 mm · 5.0 µm
PDF 3523	Amino Acids	1 compounds N-FMOC-valine	Phenomenex Chirex 3011 250 × 4.6 mm · 5.0 µm
PDF 3522	Not classified	2 compounds D-N-3.5-Dinitrobenzoylvaline L-N-3.5-Dinitrobenzoylvaline	Phenomenex Chirex 3022 250 × 4.6 mm · 5.0 µm
PDF 3521	Drugs Pharmaceuticals	1 compounds Propranolol	Phenomenex Chirex 3014 250 × 4.6 mm · 5.0 µm
PDF 3520	Drugs Pharmaceuticals	1 compounds Pindolol	Phenomenex Chirex 3022 250 × 4.0 mm · 5.0 µm
PDF 3519	Drugs Pharmaceuticals	1 compounds Propafenone	Phenomenex Chirex 3022 250 × 4.0 mm · 5.0 µm
PDF 3518	Amino Acids	1 compounds N-FMOC-leucine	Phenomenex Chirex 3011 250 × 4.6 mm · 5.0 µm
PDF 3515	Drugs Pharmaceuticals	1 compounds p-Hydroxynorephedrine	Phenomenex Chirex 3126 150 × 4.6 mm · 5.0 µm
PDF 3514	Drugs Pharmaceuticals	1 compounds p-Hydroxynorephedrine	Phenomenex Chirex 3022 250 × 4.0 mm · 5.0 µm
PDF 3513	Drugs Pharmaceuticals	2 compounds R(+)-Propranolol S(-)-Propranolol	Phenomenex Chirex 3022 250 × 4.0 mm · 5.0 µm

Showing 851–900 of 4,302

← Prev1011121314151617181920212223242526Next page →